Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 1,561,392 | 8,453,723 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 1,561,392 | 8,453,723 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 4,302,075 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 4,151,648 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 1,561,392 | 8,453,723 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 88 | 900 | 9,083 | 27,434 | 28,028 | 65,533 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 106 | 32,151 | 32,257 | |||
| 11 | Total support. Add lines 7 through 10 | 8,551,513 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2019 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2019 |
(iii) Distributable Amount for 2019 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2019 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2019: | ||||
| a From 2014....... | ||||
| b From 2015....... | ||||
| c From 2016....... | ||||
| d From 2017....... | ||||
| e From 2018....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2019 distributable amount | ||||
|
i
Carryover from 2014 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2019 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2019 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2019, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2019. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2020. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2015..... | ||||
| b Excess from 2016..... | ||||
| c Excess from 2017..... | ||||
| d Excess from 2018..... | ||||
| e Excess from 2019..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | 2019 UPDATES: 1. SELECTION OF NEW PRESIDENT & CEO 2. 2018 LIFE SCIENCES INDUSTRY CENSUS 3. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT "PATH TO 2025" 4. COLLABORATE2CURE 5. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM 6. WORKFORCE DEVELOPMENT 7. RESEARCH DEVELOPMENT GRANT PROGRAMS 8. ANNUAL DINNER AND "SCIENCE TO ART" AUCTION 9. ONE HEALTH RESEARCH SYMPOSIUM 10. ONE HEALTH DAY 11. BIOINFORMATICS 1. BIONEXUS KC ANNOUNCES DENNIS RIDENOUR AS PRESIDENT & CEO BIONEXUS KC ANNOUNCED DENNIS RIDENOUR AS THE NEXT PRESIDENT & CEO, EFFECTIVE FEBRUARY 18, 2019. DENNIS PREVIOUSLY SERVED AS THE PRESIDENT & CEO OF BIOKANSAS AND WAS A RESEARCHER AT THE STOWERS INSTITUTE FOR MEDICAL RESEARCH PRIOR TO THAT POSITION. HE BRINGS A DEEP APPRECIATION OF THE NEXUS OF HUMAN AND ANIMAL HEALTH, AND AN ESTABLISHED REGIONAL NETWORK. DENNIS IS WELL-RESPECTED FOR HIS LEADERSHIP OF BIOKANSAS, WHERE HE SUCCESSFULLY TURNED AROUND THE NON-PROFIT, EXPANDING ITS REGIONAL IMPACT THROUGH NETWORKING, ADVOCACY AND THE ADDITION OF WORKFORCE DEVELOPMENT PROGRAMS. 2. 2018 LIFE SCIENCES INDUSTRY CENSUS THE 2018 LIFE SCIENCE INDUSTRY CENSUS WAS CONDUCTED IN 2018 AND THE REPORT RELEASED IN EARLY 2019. THE LIFE SCIENCES INDUSTRY CENSUS IS THE ONLY REPEATED SYSTEMATIC ASSESSMENT OF INDUSTRY ASSETS IN THE REGION. ADDITIONALLY, THE CENSUS COLLECTS WORKFORCE DATA PROVIDING IMPORTANT INFORMATION REGARDING INDUSTRY WORKFORCE NEEDS. COMPANIES INCLUDED IN THE STUDY ARE ENGAGED IN RESEARCH AND DEVELOPMENT OR DIRECTLY SUPPORT RESEARCH AND DEVELOPMENT ACTIVITIES WITHIN THE LIFE SCIENCES. THE CENSUS DEFINES LIFE SCIENCES AS ANY RESEARCH ACTIVITIES RELATED TO THE BIOLOGY AND/OR CHEMISTRY OF ANIMALS, HUMANS OR PLANTS. BIONEXUS KC HAS PARTNERED WITH INVESTMENT RESOURCES SINCE 2006 TO CONDUCT THE CENSUS PROJECT EVERY THREE YEARS. BY USING A CONSISTENT DATA COLLECTION METHODOLOGY, EACH NEW CENSUS ADDS A LEVEL OF DEPTH TO THE INFORMATION PREVIOUSLY GATHERED AND ALLOWS FOR APPROPRIATE ANALYSIS AND COMPARISON OF DATA SETS. ESSENTIALLY EACH INDIVIDUAL CENSUS IS A CHAPTER IN THE HISTORY OF THE REGIONAL LIFE SCIENCES INDUSTRY. THE CENSUS IS AVAILABLE AT HTTPS://BIONEXUSKC.ORG/REPORTS/. 3. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT: "PATH TO 2025" BIONEXUS KC ENGAGED DELOITTE TO EXECUTE A STRATEGIC ASSESSMENT OF THE REGIONAL LIFE SCIENCES IN 2015. THE PROCESS WAS LED BY AN EXPERIENCED STEERING COMMITTEE COMPRISED OF COMMUNITY AND BUSINESS LEADERS IN THE LIFE SCIENCES. THE COMMITTEE LOOKED AT BOTH REGIONAL SCIENTIFIC STRENGTHS AND KEY DRIVERS OF CLUSTER ENHANCEMENT. THE REGIONAL VISION DEVELOPED THROUGH THE ASSESSMENT PROCESS STATES, "THE KANSAS CITY REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY." THESE NEXUS OPPORTUNITIES WILL BE DIFFERENT FOR EACH STRATEGIC AREA AND WILL LIKELY RANGE FROM USING NATURALLY OCCURRING CANCER IN DOGS FOR ACCELERATING HUMAN DISCOVERIES TO ADVANCING OUR STRENGTH IN HEALTH IT AND OUTCOMES RESEARCH. IN 2019, BIONEXUS KC CONTINUED TO ACT ON THE PATH TO 2025, LEADING PROGRAMS WHERE APPROPRIATE, CATALYZING RELATIONSHIPS AND OPPORTUNITIES, AND STIMULATING COLLABORATION TO HELP BRING EMERGING TECHNOLOGIES FROM CONCEPT TO REALITY. 4. COLLABORATE2CURE BIONEXUS KC CREATED THE COLLABORATE2CURE (C2C) PROGRAM IN 2016 WITH THE GOAL OF STIMULATING REGIONAL SCIENTIFIC COLLABORATION AND DEVELOPING INNOVATIVE WAYS TO SOLVE SCIENTIFIC CHALLENGES. THE PROGRAM PROVIDES A PLATFORM FOR COLLABORATION, ALLOWING SCIENTISTS IN THE KC REGION TO SHARE THEIR RESEARCH AND TO BETTER COMPETE FOR RESEARCH FUNDING. BIONEXUS KC IDENTIFIES A TOPIC WITH SIGNIFICANT INTEREST TO RESEARCHERS WHICH ALIGNS WELL WITH REGIONAL EXPERTISE, AND THEN COORDINATES A SERIES OF PRESENTATIONS FROM RESEARCHERS OVER THE COURSE OF SEVERAL MONTHS. IN 2019 BIONEXUS KC CONTINUED THE C2C SERIES FOCUSED ON "VALUE-BASED HEALTHCARE AND QUALITY OUTCOMES", CO-CHAIRED BY DRS. STACY FARR (UMKC) CAROLE DECKER (SAINT LUKE'S MID AMERICA HEART INSTITUTE) AND JOHN SPERTUS (UMKC). THEY ARE LEADING THE REGIONAL QUALITY & VALUE INNOVATION CONSORTIUM (QVIC), WHOSE VISION IS TO BRING MULTIPLE STAKEHOLDERS TOGETHER TO IMPROVE THE QUALITY AND VALUE OF HEALTHCARE. THE QVIC IS MADE POSSIBLE THROUGH THE REGIONAL, NIH-FUNDED, FRONTIERS: CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI) ADMINISTERED BY THE UNIVERSITY OF KANSAS MEDICAL CENTER. MULTIPLE KEY STAKEHOLDERS GATHERED DURING THE SERIES, INCLUDING RESEARCHERS, HEALTHCARE PROVIDERS, QUALITY IMPROVEMENT PROFESSIONALS, COMMERCIAL AND PUBLIC HEALTH INSURERS, STUDENTS, PATIENTS, ENTREPRENEURS, AND COMMUNITY-BASED ORGANIZATIONS. THIS C2C SERIES INCLUDED MORE THAN 650 ATTENDEES IN 2019. THE MONTHLY C2C SESSIONS CENTERED ON TOPICS AND PRIORITIES OF KANSAS CITY AREA HEALTHCARE SYSTEMS, INCLUDING OPIOID MANAGEMENT, SOCIAL DETERMINANTS OF HEALTH, PATIENT ENGAGEMENT, SATISFACTION, AND EXPERIENCE, HEALTHCARE-ASSOCIATED INFECTIONS AND CONDITIONS, AND TRANSITIONS IN CARE. THE GENERAL SESSIONS FEATURED MULTIPLE KEY STAKEHOLDERS AS THEY PRESENTED TOPICS AND CHALLENGES FROM THEIR PERSPECTIVE (INSURER, HOSPITAL, RESEARCHER, PATIENT, AND/OR CBO), FOLLOWED BY A ROUNDTABLE DISCUSSION TO IDENTIFY OPPORTUNITIES TO COLLABORATE AND ADDRESS THESE CHALLENGES. 5. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM IN 2019, THE FOCUS OF THE KC QVIC WAS TO LAUNCH TWO PILOT PROGRAMS AND BEGIN TO GENERATE DATA TO VALIDATE THE WORK OF THE CONSORTIUM: THE OPIOID PROJECT: TO REDUCE THE NEGATIVE OUTCOMES OF OPIOID USE IN THE KC REGION, KC QVIC PARTNERED WITH THE MISSOURI HOSPITAL ASSOCIATION (MHA) COMPRISED OF 144 MEMBER HOSPITALS, INCLUDING EVERY ACUTE CARE HOSPITAL IN THE STATE AND MOST OF THE FEDERAL, STATE, REHABILITATION AND PSYCHIATRIC CARE FACILITIES. MHA PARTNERED WITH SEVERAL GROUPS FROM ACROSS THE STATE TO REPLICATE AN EMERGENCY DEPARTMENT INITIATED OPIOID OVERDOSE PROGRAM ENGAGING PATIENTS IN CARE COORDINATION (EPICC). EPICC IS BASED ON A RISK REDUCTION AND RECOVERY-ORIENTED MODEL OF CARE THAT PROVIDES INTENSIVE REFERRAL SERVICES, LED BY PEER RECOVERY COACHES, TO ESTABLISH IMMEDIATE LINKAGES TO EVIDENCED-BASED TREATMENT, INCLUDING FDA-APPROVED PHARMACOTHERAPIES, PSYCHOSOCIAL SERVICES, AND RECOVERY SUPPORT. THE KC QVIC RESEARCH TEAM WORKED WITH EACH CLINICAL SETTING TO ENHANCE THE MHA'S IMPLEMENTATION, AND PROVIDED IN-DEPTH EVALUATION OF THE PROGRAM OUTCOMES. THE TRANSITIONS IN CARE PROJECT: EVERY HOSPITAL IN THE US STRUGGLES WITH HIGH READMISSION RATES SHORTLY AFTER DISCHARGE. KC QVIC SELECTED HEART FAILURE AS A PROTOTYPICAL CONDITION FOR WHICH READMISSIONS ARE A PROBLEM. HEART FAILURE IS A 'CAROUSEL' WHEREBY PATIENTS WITH CHRONIC HEART FAILURE EXPERIENCE EXACERBATIONS THAT DRIVE THEM TO THE EMERGENCY DEPARTMENT WHERE, MORE THAN 80% OF THE TIME, THEY ARE ADMITTED, TREATED AND DISCHARGED, ONLY TO BE READMITTED. TO HELP HOSPITALS, ALMOST A DOZEN DIFFERENT EVIDENCE-BASED STRATEGIES HAVE BEEN IDENTIFIED BY THE KC QVIC AND WERE IMPLEMENTED ACROSS THE KC REGION. BOTH OF THE ABOVE PROGRAMS APPROACH CARE FROM A BROAD, PATIENT-CENTERED, HOLISTIC PERSPECTIVE THAT WILL LEVERAGE RESOURCES FROM BOTH THE HEALTHCARE SYSTEM AND THE COMMUNITY TO IMPROVE CARE. WORKING IN PARTNERSHIP WITH BIONEXUS KC, THE KC QVIC WILL USE THESE PROGRAMS TO DEMONSTRATE THAT THESE APPROACHES CAN IMPROVE PATIENT OUTCOMES AND LOWER THE COST OF CARE FOR THOSE IN THE KC REGION. WHILE THE ENTIRE COUNTRY IS GRAPPLING WITH THE CHALLENGE OF IMPROVING THE QUALITY OF CARE WHILE LOWERING COSTS, KANSAS CITY CAN MODEL THE UNIQUE CULTURE AND ASSETS OF OUR REGION AS IT STRIVES TO BECOME "THE OUTCOMES CAPITOL". 6. WORKFORCE DEVELOPMENT WORKFORCE DEVELOPMENT WAS IDENTIFIED IN BIONEXUS KC'S PATH TO 2025 REPORT AS A SIGNIFICANT THREAT TO AND CRITICAL WEAKNESS IN THE REGIONAL LIFE SCIENCE CLUSTER. 2019 ACTIVITIES IN SUPPORT OF WORKFORCE DEVELOPMENT INCLUDED THE FOLLOWING: - STRONG STEM LEARNING ECOSYSTEMS FEATURE DYNAMIC COLLABORATIONS AMONG SCHOOLS, STEM EXPERT INSTITUTIONS (MUSEUMS, SCIENCE CENTERS, ETC.), THE PRIVATE SECTOR, COMMUNITY-BASED ORGANIZATIONS, YOUTH AND FAMILIES. KANSAS CITY WAS IN THE FIRST COHORT OF THE NOW 89 CITIES/REGIONS FORMING THE STEM LEARNING ECOSYSTEM COMMUNITY OF PRACTICE. THE KC STEM ALLIANCE HAS PROVIDED THE INFRASTRUCTURE TO SUPPORT THE ORGANIZATION OF STEM RESOURCES IN THE REGION WITH ASSISTANCE FROM NEARLY 20 COMMUNITY ORGANIZATIONS, INCLUDING BIONEXUS KC. - AS THE NATIONAL STEM LEARNING ECOSYSTEMS COMMUNITY OF PRACTICE EXPANDED, THERE WAS A NEED TO DEVELOP A BUSINESS MODEL AND AN ORGANIZATIONAL GOVERNANCE STRUCTURE TO ENSURE LONG-TERM SUSTAINABILITY OF THIS IMPORTANT NATIONAL NETWORK. BIONEXUS KC VICE PRESIDENT, DR. KEITH GARY, WAS INVITED TO PARTICIPATE WITH A GROUP OF 35 INDIVIDUAL STEM ECOSYSTEM LEADERS (ECOSYSTEM ADVISORY COMMITTEE) FROM ACROSS THE UNITED STATES TO UNDERTAKE THIS IMPORTANT WORK. THE FRAMEWORK THAT EMERGED WILL BE INTEGRATED NATIONALLY IN 2020. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | A KEY RECOMMENDATION FROM THE LIFE SCIENCES TALENT TO INDUSTRY EXCHANGE (TIE) PROCESS, CONDUCTED AS PART OF KC RISING, WAS TO ESTABLISH A REGIONAL ADVISORY COUNCIL (RAC). THE RAC CAN ASSESS A VARIETY OF WORKFORCE ISSUES AND IDENTIFY EDUCATION SOLUTIONS MORE RAPIDLY, EFFICIENTLY, AND MEETING INDUSTRY NEEDS. - BIOINFORMATICS WAS SELECTED AS THE FIRST FOCUS AREA FOR THE RAC, AS COMPANIES IN THIS INDUSTRY SECTOR STRUGGLE TO ACQUIRE ADEQUATELY SKILLED WORKERS. THE RAC IS CO-CHAIRED BY BARBARA BICHELMEYER (PROVOST, UMKC) AND HARLEN HAYS (MANAGER, LEAD ANALYTICS ADVISER, CERNER). THE FIRST MEETING INCLUDED REPRESENTATIVES FROM THE BIOINFORMATICS INDUSTRY, K-12 EDUCATION, HIGHER EDUCATION, THE PUBLIC WORKFORCE SYSTEM, AND EDUCATION INTERMEDIARIES. TOPICS SUCH AS THE PURPOSE OF THE RAC, A LOGIC MODEL GUIDING THE RAC'S WORK, AND EXAMPLES OF ON-DEMAND CURRICULA CREATED WITH INDUSTRY INPUT WERE DISCUSSED. THE GROUP WORKS CLOSELY WITH CERNER, NETSMART, AND IQVIA COMPANIES EMPLOYING 80% OF THE BIOINFORMATICS WORKFORCE. - CONTRACT RESEARCH ORGANIZATIONS WILL BE THE SECOND FOCUS AREA. GIVEN THE EVER-CHANGING NATURE OF THEIR WORKFLOW, THIS INDUSTRY SECTOR IS RIPE FOR USING STACKABLE CREDENTIALS TO MEET TRAINING NEEDS. THESE SHORT-TERM CREDENTIALS CAN BE "STACKED," LEADING TO TWO AND FOUR-YEAR DEGREES. 7. BIONEXUS KC'S RESEARCH DEVELOPMENT GRANT PROGRAMS BIONEXUS KC'S RESEARCH DEVELOPMENT GRANTS PROGRAM IS DESIGNED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS IS A VALUED SERVICE APPRECIATED BY ALL TEN STAKEHOLDERS. THE BIONEXUS KC GRANT PROGRAM HAS AWARDED 108 GRANTS TOTALING $5 MILLION SINCE THE PROGRAM LAUNCHED IN 2002. THE INTENT OF THE GRANT PROGRAM IS TO BETTER POSITION RESEARCHERS TO COMPETE FOR LARGER FEDERAL GRANTS. FOR EVERY GRANT DOLLAR AWARDED BY BIONEXUS KC, $11.70 RETURNS TO THE REGION IN FROM FEDERAL AGENCIES. THE TOTAL RETURN ON INVESTMENT CURRENTLY STANDS AT $58.9 M AND IT CONTINUES TO GROW. THE 2019 BIONEXUS KC RESEARCH DEVELOPMENT GRANT PORTFOLIO INCLUDES: THE BLUE KC "TRANSFORMING KC HEALTH RESEARCH GRANT" (FORMERLY OUTCOMES RESEARCH) PROGRAM: SINCE 2012, BLUE CROSS BLUE SHIELD OF KANSAS CITY (BLUE KC) HAS GIVEN OVER $1 MILLION TO HEALTH OUTCOMES RESEARCH FUNDING THROUGH THE BIONEXUS KC OUTCOMES RESEARCH GRANT PROGRAM. THE 2019 TRANSFORMING KC HEALTH RESEARCH GRANT FOCUSED ON PARTNERSHIPS THAT AIMED TO ADDRESS SOCIOECONOMIC AND ENVIRONMENTAL BARRIERS TO HEALTH, SPECIFICALLY THROUGH RESEARCH ON IMPROVING ACCESS TO NUTRITIOUS FOODS IN NUTRITIONALLY INSECURE COMMUNITIES, AND WAS AWARDED TO THE PARTNERSHIP BETWEEN THE COMMUNITY HEALTH COUNCIL OF WYANDOTTE COUNTY (CHC), THE UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE (KUMC) AND VIBRANT HEALTH. THE RESEARCH WILL NOT ONLY IDENTIFY SUCCESSFUL STRATEGIES TO ENSURE MEMBERS HAVE SUSTAINABLE ACCESS TO HEALTHY FOOD AND THE CAPACITY FOR HEALTH FOOD PREPARATION, BUT ALSO DEMONSTRATE ASSOCIATED IMPROVEMENTS IN HEALTH OUTCOMES. THE PARTNERSHIP WILL RECEIVE UP TO $400,000 OVER TWO YEARS. PAUL PATTON CHARITABLE TRUST GRANTS: THIS GRANT PROGRAM FOCUSES ON GENETIC DISEASES MAINLY AFFECTING CHILDREN. THE FUNDS FOR THIS PROGRAM ARE PROVIDED BY THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS JR. AND BANK OF AMERICA, N.A., TRUSTEE. BIONEXUS KC AWARDED GRANTS OF UP TO $50,000 TO THREE RESEARCHERS, TWO AT THE UNIVERSITY OF KANSAS MEDICAL CENTER AND ONE AT CHILDREN'S MERCY. NEXUS OF HUMAN AND ANIMAL HEALTH GRANTS: THIS GRANT PROGRAM FOCUSES ON BIOMEDICAL RESEARCH PROJECTS, RANGING FROM USING NATURALLY OCCURRING DISEASES IN ANIMALS AS A MODEL FOR ASSESSING HUMAN DRUG EFFICACY TO REPURPOSING HUMAN DRUGS FOR USE IN ANIMAL DISEASES. IN 2019, FUNDED BY THE HALL FAMILY FOUNDATION, BIONEXUS KC AWARDED $50,000 GRANTS TO TWO RESEARCHERS, ONE AT THE UNIVERSITY OF KANSAS MEDICAL CENTER AND THE OTHER AT THE UNIVERSITY OF MISSOURI-KANSAS CITY. 8. 2019 ANNUAL DINNER AND "SCIENCE TO ART" AUCTION OVER 500 COMMUNITY LEADERS, SCIENTIFIC LEADERS, AND COLLEGE AND HIGH SCHOOL STUDENTS ATTENDED THE OCTOBER 10 "DATA TO DECISIONS" ANNUAL DINNER AT THE ARVEST BANK THEATRE AT THE MIDLAND. BELOW ARE HIGHLIGHTS FROM THIS YEAR'S EVENT: DR. JESSILYN DUNN, PHD, ASSISTANT PROFESSOR OF BIOMEDICAL ENGINEERING, BIOSTATISTICS, AND BIOINFORMATICS AT DUKE UNIVERSITY PROVIDED THE KEYNOTE, PRESENTED ON THE TOPIC, "BIG DATA APPLICATIONS FOR IMPROVED HEALTH OUTCOMES: USING WEARABLES, EHR AND -OMICS DATA FOR EARLY DETECTION, INTERVENTION, AND PREVENTION OF DISEASE." SHE PRESENTED HER RESEARCH ON INTEGRATING DATA FROM WEARABLE DEVICES, ELECTRONIC HEALTH RECORDS, AND GENOMICS WORK IN DISCOVERING EFFECTIVE AND CUSTOMIZED TREATMENT PLANS TAILORED TO INDIVIDUAL PATIENTS. INCOMING PRESIDENT & CEO DENNIS RIDENOUR WAS WELCOMED BY BOARD DIRECTORS BILL BERKLEY AND DEBORAH WILKERSON. THE SCIENCE TO ART SILENT AUCTION RAISED OVER $6,000 WHICH WAS MATCHED BY BIONEXUS KC TO SUPPORT STEAM EDUCATION, SPECIFICALLY BIOGENEIUS, PREP-KC, SCIENCE CITY AND THE GREATER KANSAS CITY SCIENCE & ENGINEERING FAIR, AND FREE EDUCATIONAL PROGRAMS AT THE KEMPER MUSEUM. 9. ONE HEALTH RESEARCH SYMPOSIUM BIONEXUS KC HOSTED THE ANNUAL ONE HEALTH RESEARCH SYMPOSIUM ON AUGUST 25 & 26 FOCUSED ON "IMMUNOTHERAPY: ACTIVATING YOUR IMMUNE SYSTEM TO FIGHT DISEASE." IMMUNOTHERAPY TREATMENT IS DESIGNED TO ACTIVATE THE BODY'S IMMUNE SYSTEM TO BETTER RECOGNIZE AND FIGHT DISEASE. SEVERAL IMMUNOTHERAPEUTICS HAVE BEEN APPROVED TO FIGHT DISEASE, AND HUNDREDS MORE ARE BEING TESTED IN CLINICAL TRIALS. BELOW ARE HIGHLIGHTS FROM THIS YEAR'S EVENT: OVER 100 ATTENDEES, INCLUDING STUDENTS, POST-DOCS AND INDUSTRY PROFESSIONALS FROM SEVEN STATES ACROSS OUR REGION HEARD FROM 20+ SPEAKERS AT THE KANSAS CITY CONVENTION CENTER ABOUT THE LATEST IN IMMUNOTHERAPY APPROACHES AND TREATMENTS. A KEYNOTE SPEAKER KICKED OFF EACH DAY'S PROGRAM. - DR. KLAUS HELLMAN, MANAGING DIRECTOR, KLIFOVET AG PRESENTED ON: ARTICELL FORTE: THE FIRST CHONDROGENIC INDUCED STEM CELL BASED VETERINARY MEDICINE FOR HORSES." - LEONID METLITSA, MD, PHD, PROFESSOR OF PEDIATRICS AND IMMUNOLOGY, TEXAS CHILDREN'S CANCER CENTER, CENTER FOR CELL & GENE THERAPY AT BAYLOR COLLEGE OF MEDICINE PRESENTED ON "HARNESSING NATURAL AND ENGINEERED PROPERTIES OF NKT CELLS FOR ADOPTIVE CANCER IMMUNOTHERAPY." 10. ONE HEALTH DAY BIONEXUS KC PARTNERED WITH KANSAS STATE UNIVERSITY, BIOKANSAS, KU EDWARDS, AND FRONTIERS: UNIVERSITY OF KANSAS CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE FOR THE NOVEMBER 6, 2019 "KANSAS CITY ONE HEALTH DAY." THIS EVENT IS PART OF AN ANNUAL, INTERNATIONAL EVENT FOCUSED ON COMPLEX COLLABORATIONS ACROSS MULTIPLE DISCIPLINES TO ACHIEVE OPTIMAL HEALTH FOR PEOPLE, ANIMALS, AND THE ENVIRONMENT REFERRED TO AS ONE HEALTH. THE EVENT FEATURED SEVERAL PROMINENT RESEARCHERS IN THE BI-STATE REGION WHO EXPLORED VARIOUS ASPECTS OF "CLIMATE CHANGE AND EXTREME WEATHER EVENTS." THE EVENT INCLUDED A STUDENT POSTER COMPETITION WITH SIX GRADUATE AND SIX HIGH SCHOOL STUDENTS COMPETING FOR SCHOLARSHIPS. 11. BIOINFORMATICS IN PARTNERSHIP WITH CHILDREN'S MERCY AND THE UNIVERSITY OF MISSOURI-KANSAS CITY, BIONEXUS KC PRESENTED THE FOURTH ANNUAL MIDWEST BIOINFORMATICS CONFERENCE ON APRIL 11-12, 2019. THE GOAL OF BIOINFORMATICS IS TO EXPAND OUR UNDERSTANDING OF BIOLOGICAL PROCESSES BY DEVELOPING AND APPLYING COMPUTATIONALLY INTENSIVE TECHNIQUES LIKE PATTERN RECOGNITION, DATA MINING, MACHINE LEARNING ALGORITHMS, AND VISUALIZATION. BELOW ARE HIGHLIGHTS FROM THIS YEAR'S EVENT: - FEATURING CLOSE TO 30 SPEAKERS, THIS EVENT BROUGHT TOGETHER NEARLY 200 BIOINFORMATICS-MINDED RESEARCHERS FROM ACADEMIA AND INDUSTRY TO DISCOVER CAPABILITIES, SHARE TACTICAL APPROACHES TO PROBLEM-SOLVING, AND EXPLORE SYNERGIES AND POTENTIAL COLLABORATIONS. - BIOINFORMATICS STUDENTS LEARNED ABOUT EMPLOYMENT OPPORTUNITIES WITHIN THE REGION AND WERE ABLE TO PARTICIPATE IN MOCK INTERVIEWS WITH REGIONAL EMPLOYERS. - A SUBSET OF STUDENT POSTERS WERE CONSIDERED FOR PODIUM PRESENTATIONS, WITH FOUR STUDENTS SELECTED FOR THIS HONOR. - A KEYNOTE SPEAKER KICKED OFF EACH DAY'S PROGRAM. -WENDY CHAPMAN, PHD, JON M. HUNTSMAN PRESIDENTIAL ENDOWED CHAIR, DEPARTMENT OF BIOMEDICAL INFORMATICS WITH THE UNIVERSITY OF UTAH PRESENTED ON "INFORMATICS AS A JOURNEY: HOW YOUR EXPERTISE IS NEEDED IN THE GRAND GOAL OF TRANSFORMING HEALTHCARE." -SCOTT SHEARER, PHD, PE, PROFESSOR AND CHAIR OF THE FOOD, AGRICULTURAL AND BIOLOGICAL ENGINEERING WITH OHIO STATE UNIVERSITY PRESENTED ON "DIGITAL AGRICULTURE DISRUPTION OR DISTRACTION?" |
| FORM 990, PART VI, SECTION A, LINE 2 | ANNE D. ST. PETER AND STEVEN ST. PETER,MD HAVE A FAMILY RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. |
| FORM 990, PART VI, SECTION B, LINE 15A | COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. |
| Software ID: | |
| Software Version: |